Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 19 von 994

Details

Autor(en) / Beteiligte
Titel
Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis
Ist Teil von
  • Vaccine, 2006-05, Vol.24 (18), p.3909-3920
Ort / Verlag
Oxford: Elsevier Ltd
Erscheinungsjahr
2006
Quelle
MEDLINE
Beschreibungen/Notizen
  • The adjuvant of the FML-vaccine against murine and canine visceral leishmaniasis, the Riedel de Haen saponin mixture, was fractionated by ion exchange chromatography on DEAE-cellulose to afford one TLC homogeneous Quillaja saponaria Molina QS21 saponin fraction (18.0%), a mixture of two deacylsaponins (19.4%), sucrose (39.9%), sucrose and glucose (19.7%), rutin (0.8%) and quercetin (2.2%), that were identified by comparison of 1H and 13C NMR spectroscopy. The QS21 shows the typical aldehyde group in C-23 (65% equatorial) and a normonoterpene moiety acylated in C-28. The deacylsaponins show the aldehyde group but do not have the normonoterpene moiety. Balb/c mice were vaccinated with 150 μg of FML antigen of Leishmania donovani and 100 μg of each obtained fraction and further challenged by infection with 10 8 amastigotes of Leishmania chagasi. The safety analysis and the effect on humoral and cellular immune responses and in clinical signs showed that the QS21 saponin and the deacylsaponins are the most active adjuvant compounds of the Riedel the Haen saponin mixture. Both induced the highest and non-significantly different increases in DTH, CD4+ T lymphocytes in spleen, IFN-γ in vitro, body weight gain and the most pronounced reduction of parasite burden in liver (95% for QS21 and 86% for deacylsaponins; p > 0.05). While the QS21 showed mild toxicity, significant adjuvant effect on the anti-FML humoral response before and after infection, and decrease in liver relative weight, the deacylsaponins showed no toxicity, less haemolysis and antibody and DTH responses increased mainly after infection, still inducing a stronger Leishmania-specific in vitro splenocyte proliferation. Our results confirm in the Riedel de Haen saponin extract the presence of deacylsaponins normonoterpene-deprivated which are non-toxic and capable of inducing a specific and strong immunoprotective response in vaccination against murine visceral leishmaniasis.
Sprache
Englisch
Identifikatoren
ISSN: 0264-410X
eISSN: 1873-2518
DOI: 10.1016/j.vaccine.2006.02.034
Titel-ID: cdi_proquest_miscellaneous_17172915
Format
Schlagworte
Acylation, Adjuvants, Immunologic - administration & dosage, Animals, Antibodies, Protozoan - blood, Antigens, Protozoan - administration & dosage, Antigens, Protozoan - immunology, Applied microbiology, Biological and medical sciences, CD4-Positive T-Lymphocytes - immunology, Chromatography, Ion Exchange, Deacylated saponins, Disease Models, Animal, Enzyme-Linked Immunosorbent Assay, Female, FML-vaccine, Fundamental and applied biological sciences. Psychology, Hemolysis, Human protozoal diseases, Hypersensitivity, Delayed, Infectious diseases, Interferon-gamma - biosynthesis, Lectins - administration & dosage, Lectins - immunology, Leishmania chagasi, Leishmania donovani, Leishmania donovani - immunology, Leishmaniasis, Visceral - immunology, Leishmaniasis, Visceral - parasitology, Leishmaniasis, Visceral - pathology, Leishmaniasis, Visceral - prevention & control, Leshmaniasis, Liver - parasitology, Liver - pathology, Magnetic Resonance Spectroscopy, Medical sciences, Mice, Mice, Inbred BALB C, Microbiology, Molecular Structure, Murine visceral leishmaniasis, Parasitic diseases, Plant Extracts - chemistry, Plant Extracts - immunology, Protozoal diseases, Protozoan Vaccines - immunology, QS21 saponin, Quillaja - chemistry, Quillaja saponaria, Quillaja saponaria Molina, Saponins, Saponins - administration & dosage, Saponins - chemistry, Saponins - immunology, Saponins - toxicity, Spleen - immunology, Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX